Search | Page 33 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. SCT Plus Immune Therapy in Average Risk AML/MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 9:52am.

  2. Study of INCB053914 in Subjects With Advanced Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/02/2016 - 4:09pm.

  3. IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... will be exposed to an excessive risk if entered into this clinical study Active heart disease including myocardial infarction within ...

    Clinical Trial last updated 04/29/2016 - 11:05am.

  4. Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/02/2016 - 2:38pm.

  5. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.

  6. Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS (UPCI 13-165)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... data shows that it is well tolerated and effective in clinical use for the treatment of AML or MDS relapse after HCT, as well as for ...

    Clinical Trial last updated 04/29/2016 - 10:26am.

  7. GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... inv 16). Secondary AML ALL/LL in 1st remission with clinical or molecular features indicating a high risk for relapse; or ALL > 2nd ...

    Clinical Trial last updated 04/29/2016 - 12:40pm.

  8. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... or > than or = to 2nd remission ALL/CLL in 1st remission clinical or molecular features indicating a high risk for relapse; or ALL/CLL > ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  9. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... 1st relapse or > 2nd remission ALL/LL in 1st remission clinical or molecular features indicating a high risk for relapse; or ALL > 2nd ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  10. T-cell Depleted Alternative Donor Transplantation

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... ejection fraction < 45%; can be lower if patient is not in clinical cardiac failure and a reduced intensity conditioning regimen is used. ...

    Clinical Trial last updated 04/29/2016 - 3:38pm.